Description:

An analysis of Lexicon Pharmaceutical's Sotagliflozin and why the FDA will approve this drug in treating Type 1 Diabetes. I believe that the stock price of Lexicon Pharmaceuticals will rapidly go up on March 22, 2019 in response to the FDA approval of this medicine, with restrictions of course.